Pulnovo Medical

medical devices

About

Pulnovo Medical Limited is a medical device company founded in 2013 and headquartered in Wuxi, China. The company specializes in innovative treatments for pulmonary hypertension (PH) and heart failure (HF). With a strong international presence, Pulnovo Medical conducts clinical activities across the United States, Europe, Asia, and the Middle East, focusing on addressing critical needs in cardiovascular care. The company's flagship product is the Pulmonary Artery Denervation (PADN) System, which utilizes radiofrequency ablation technology to treat patients with pulmonary hypertension. The PADN system includes a multi-pole RF ablation catheter and generator, designed to reduce pulmonary artery pressure through a minimally invasive procedure. Pulnovo Medical is committed to expanding patient access to its therapies and has established partnerships with healthcare providers and payers to facilitate this goal. The company has achieved several regulatory milestones, including FDA Breakthrough Device Designation and CE-MDR certification, further solidifying its position in the global market.

Technologies

Amazon AWS Microsoft Office 365 Nginx Mobile Friendly

Keywords

ph pulmomary hypertension pulmonary arterial hypertension pah heart failure hf medical equipment manufacturing guideline inclusion fda clearance biotechnology medical devices innovative technology clinical trials clinical research cardiology healthcare equipment & supplies fda ide approval services pulmonary hypertension product approval pulmonary artery denervation clinical study portugal clinical investigation humanitarian device medical device regulation heart failure therapy regulatory pathway denervation technology therapeutic solutions global healthcare

Location

Shanghai, Shanghai, China

Related Companies

Companies in the same industry